1
By JAN LEE [email protected] UNITED World College South East Asia’s (UWCSEA) Dover campus will soon include Sin- gapore’s most energy-effi- cient office with space-saving techniques. The project will be spear- headed by Future Cities Labo- ratory (FCL), a research pro- gramme focused on urban sustainability. FCL is part of Singapore ETH Centre (SEC), the only research centre out- side of Switzerland under the umbrella of the prestigious Swiss Federal Institute of Technology Zürich (ETH Zürich). The 600 sqm office situat- ed in a 20,000 sqm building will be the first commercial application of the ‘3for2’ ar- chitecture here when it is completed in 2015. The ‘3for2’ concept allows building developers to con- struct three floors within the standard space needed for conventional methods to con- struct two floors without any impact on perceived floor-to-ceiling heights. Currently, up to a quarter of vertical spaces in local of- fices are occupied by duct- work, structures and other technical systems. However, the team behind ‘3for2’ has found a way to greatly reduce the amount of ductwork need- ed and integrate the remain- ing ductwork into the floor, thereby saving on a large amount of headspace. The ‘3for2’ design also saves on space and energy consumption through new construction technologies such as LED lighting panels and passively cooled ceiling tiles. The new office will also employ a more energy effi- cient chilling system for its air-conditioning, which ac- counts for the bulk of energy costs in modern Singapore of- fices. This is achieved via in- creasing the overall chilled water temperature required to chill a space from about 6 degrees to about 17 degrees. The office is expected to con- sume 40 per cent less energy than an average office in Sin- gapore. Reducing energy con- sumption while increasing vi- able space seems to have hit architectural jackpot. Yet, as a new concept to local proper- ty developers, ‘3for2’ has yet to gain traction. In fact, the UWCSEA ‘3for2’ office is a mere 3 per cent of the new building’s floor space. Howev- er, the FCL team believes that starting small is good enough. Dr Adam Rysanek, SEC FCL manager of the ‘3for2’ implementation at UWCSEA said: “Before we can really consider applying our con- cept throughout a 50-storey skyscraper, we need to make sure we get the basics right. With our project at UWCSEA, we have to first prove that our system will deliver the most energy-efficient office space in the region.” T O the naked eye, the capsules produced by biotechnology firm Austrianova look like brightly coloured balls, each barely a millimeter in diame- ter. But each one of these capsules is in fact a pod capable of containing 10,000 living cells. Professor Walter Gunzburg, the chairman and chief technology officer of Austrianova, explained that the cap- sules are made of a special type of cot- ton, designed to protect the cells and cocoon them so they can grow and do the job they need to do – for these cells, contained in their pods, are to be injected into the human body for a variety of potential applications – from cancer treatment to probiotics, stem cells and cosmetics. The special cotton of which the cap- sules are made also ensure that the body’s immune system does not re- ject the cells, he said. “We take living cells and we mix them with this cotton material – this special proprietary cotton derivative which we manufacture ourselves. When you mix the two together you form these capsules, with the cells in- side.” This is what Austrianova’s Cell-in-a-Box or cell encapsulation technology is about – and it could change the way medication is admin- istered to patients. The capsules are all porous, to al- low for the movement of substances in and out. This way, the cells inside can draw nutrition from outside and expel waste; the porous membrane al- so enables useful substances pro- duced by the cell to enter the body. Prof Gunzburg said: “What we’re doing here is making a mini implant. Instead of manufacturing a pharma- ceutical product in a factory, putting it in a bottle, sending it to the hospital and then administering it to the pa- tient, we are actually moving the facto- ry into the patient.” Diabetes patients, for example, are injected with these capsules contain- ing insulin-producing cells, which can be programmed with mechanisms to react to the body, only producing as much insulin as is needed each time. Dosing in this way will be more precise, compared to the convention- al method of making rough estima- tions for each dose, or relying on a fixed dose regardless of changes in the body. The system is thus self-regulating, which takes some burden off patients from having to monitor their doses. Austrianova’s most advanced pro- gramme so far is in the treatment of pancreatic cancer, which has been in two clinical trials in Europe involving 27 patients with advanced stages of the disease. Prof Gunzburg said existing drugs have a small effect on one’s survival and reduce pain, but cause a range of side effects. The pancreatic cancer patients have been injected with capsules con- taining cells that have been genetical- ly modified to activate the chemother- apeutic chemicals these patients are administered. So the chemotherapy is activated only where these cells land up. Austri- anova’s chief executive Dr Brian Sal- mons said: “It’s like a magnifying glass, focusing the effect on the tu- mour. This allows you to go in with a low dose, so that you don’t really get many side effects. So you get better an- ti-tumour activity and fewer side ef- fects as well.” Results of the trials have so far been promising: the patients have a median survival period of 40 weeks, double that of the current gold stand- ard treatment. In eight of the 27 pa- tients, the tumours shrank as well. Cell-encapsulation pioneer Austrianova is the only company in the world using its proprietary cotton material to advance cell-encapsula- tion technology. The material of which the capsules are made enables the capsules to be frozen and shipped around the world and stored for up to five years. Most other cell products need to be used im- mediately, making logistics more cost- ly and complicated. Austrianova’s operations are pri- marily partner-based. The company has around 10 partners worldwide, with whom it conducts research and development and leverages on their expertise in order to deliver a custom- ised product. “It’s very customised. Once the pro- duction process is set, it’s very sim- ple: you just put the cells and the cot- ton together at the beginning and the beads come out at the end. But how you tweak the cells, how you tweak the cotton to make the perfect bead for the perfect application, like the size of the bead, the size of the holes – that’s all stuff that we tweak,” said Prof Gunzburg. Interestingly, this business model differs from what the founders of Aus- trianova initially had in mind. The company rose in Austria, with its original focus being to develop all stages of its product for pancreatic cancer, but this was an extremely cost- ly mission. Austrianova thus went from devel- oping its own product to being a tech- nology platform, and this is how the company came to be in Singapore, known for its vibrant stem cell com- munity. Singapore became the compa- ny’s stepping stone into Asia when it set up here in 2007. But what Singapore lacks, com- pared to Europe, was a venture capi- tal culture. Austrianova adapted. It has since built itself here by relying on financ- ing from high-net-worth individuals. It has also placed a premium on avoid- ing risks and diversifying the compa- ny’s offerings, instead of being fo- cused on a single product as is the norm in Europe. Dr Salmons said: “In the past, we used to focus on our oncology prod- uct, but now, we’ve got many horses in the race, different ways to make products and generate income. “As a company offering a technolo- gy platform, we work with other part- ners who have specific needs. So they have cells which they would like to use for some particular application; they come to us and we co-develop the product with them.” Prof Gunzburg agreed, saying: “The most important thing is to keep the company liquid and move the com- pany forward, and you have to find a way to do that, whatever it takes.” Subsidiary in Thailand The company’s cash flow comes from its clients, who pay for every stage of their product development with Aus- trianova. It also places an emphasis on mini- mising costs and keeping the compa- ny’s burn rate low by outsourcing functions on a pay-by-use system; it does this with its financial services, business development and legal ad- vice functions. Austrianova has also set up a sub- sidiary in Thailand, which it fully owns. This unit concentrates on the manufacturing of medical products for global export and be off the ground by the end of the year. Thailand was chosen because it is cheaper, more cost-efficient than Sin- gapore, said Prof Gunzburg. The com- pany hopes to begin manufacturing its pancreatic cancer product for fur- ther patient trials by the first half of next year. Dr Salmons said: “Running a com- pany is not just about making money. It is important to bring your investors a return, but it is also because there’s a medical need out there for which we want to develop products that will ac- tually help patients eventually.” Prof Gunzburg said: “We’re build- ing a company that should grow and be around in 10 years’ time. We are trying to build something that is sus- tainable.” By LEE MEIXIAN [email protected] @LeeMeixianBT MORE companies across the world are engaging in environmental and socially responsible activities - not simply for brand building or altruistic reasons, but simply because it makes good financial sense. This was according to the latest re- search by Grant Thornton which has been tracking business attitudes to cor- porate social responsibility (CSR) since 2008. In Singapore, the top five drivers to- wards more sustainable business prac- tices are: cost management (73 per cent), followed by client or consumer de- mand (62 per cent), “because it is the right thing to do” (55 per cent), tax relief (51 per cent), and recruitment and re- tention of staff (44 per cent). For instance, over the last 12 months, more than half of Singapore businesses have started calculating their carbon footprint. This is the No 1 CSR initiative adopted here. Singapore companies also donate products or services to community and charities (47 per cent), partner a charita- ble organisation for philanthropy (45 per cent) and donate money (43 per cent). The survey of 2,500 businesses in 34 economies was conducted in May this year, and interviewed C-Suite and other senior decision-makers in mid-market businesses - of which 50 were Singa- pore business leaders. It also found that more companies are also reporting on sustainability, while a majority now view integrated re- porting as best practice. Since Singapore Exchange intro- duced sustainability reporting guide- lines in 2011, many major corporations in Singapore have included a CSR com- ponent in their business framework to align with the global investor expecta- tions, it said. Austrianova runs a tight ship here as it grows its business of delivering medical treatments in ‘capsules’. AMANDA EBER reports By CAI YONG [email protected] FRAUDSTERS are operating through money mules and even using unwit- ting blogshop owners to scam online shoppers, said the Singapore Police Force yesterday. New statistics indicate that cheat- ing cases involving e-commerce jumped 425 per cent in the first half of this year from the corresponding period a year ago. Lian Ghim Hua, the deputy assist- ant commissioner of police and com- mander of the Ang Mo Kio Police Divi- sion, said: “I think it’s a general reflec- tion of how more and more people have started to engage in e-com- merce... And with that, criminals are also looking to exploit this space to pursue some of their illicit activities.” Multiple payment online purchase (MPOP) scams, for example, have ris- en from 13 in the first half of last year to 302 reported cases in the first half of this year. The amounts swindled are now al- so larger – at least $237,000 in the first half of this year from S$28,000 last year. In MPOP scams, the perpetrators put up online advertisements offering to sell items at heavy discounts. Their victims, drawn to the deals, contact them and are instructed to send pay- ment, typically through bank trans- fers. The cash goes to local accounts held by money mules, who then trans- fer the sum to the masterminds. The goods are never delivered. When the victims enquire on the de- lay, they are told to pay additional fees in order to receive their orders; the victims pay until they realise they have been duped. Police have stepped up efforts against these fraudsters. In a two-day operation that ended yesterday, they arrested six men and 12 women, Sin- gaporeans aged 16 to 47 suspected of having been money mules for MPOP scams. Preliminary investigations suggest that the masterminds are in Africa. Some money mules are recruited un- der the pretext of a work-from-home job, others, with promises of love. In rare cases, scammers have also operated through blogshop owners. These scammers contact blogshop owners, feigning interest their prod- ucts. They then go to their victims, in- structing them to deposit amounts far higher than the price of those items in- to the bank account of the blogshop. The scammers then close in, tell- ing the blogshop owners that they had mistakenly overpaid, and ask that these owners transfer the excess payment to their bank account. Police have warned members of the public to be wary of deals that are too good to be true, and to buy only from sellers with strong track records. Legitimate businesses will find it harder to get a footing in cyberspace; new online shops, with no history to speak of, will find it even more diffi- cult to build their customer base. More firms find CSR makes financial sense Biotech firm a leader in cell-encapsulation Rising cyber scams make it tough for genuine businesses to get firm foothold UWC Dover campus office to also have energy-efficient solutions Cell-in-a-Box know-how: The key personnel in Austrianova are (from left) chief operating officer Dr John Dangerfield, chairman and chief technology officer Dr Walter Gunzburg and president and chief executive officer Dr Brian Salmons PHOTO: YEN MENG JIIN Conventional building ‘3for2’ building Flat, cold water radiators attached to ceiling Bulky mechanical equipment hidden along exterior of facade Sloped windows for improved daylight quality Ductwork integrated into concrete slabs Source: Future Cities Laboratory 2014 Test case for space saving building method This profile is the 13th of a series o f features on the 16 finalists of the Emerging Enterprise Award 2014. Jointly presented by The Business Times and OCBC Bank, the Emerging Enterprise Award 2014 recognises promising enterprises and startups which are up to 10 years old and have an annual turnover of S$15 million or less. It is supported by RSM Chio Lim, MasterCard, SingTel, ACORN Marketing & Research Consultants, INSEAD and SPRING Singapore. The winners will be unveiled at a gala dinner on August 29. Online scams up 425% in H1 from year ago The Business Times, Thursday, August 21, 2014 SINGAPORE NEWS 9

Online scams Test case for space saving building method up ... · charities(47 percent),partner acharita-ble organisation for philanthropy (45 per cent) and donate money (43 per cent)

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Online scams Test case for space saving building method up ... · charities(47 percent),partner acharita-ble organisation for philanthropy (45 per cent) and donate money (43 per cent)

By JAN [email protected] World College SouthEast Asia’s (UWCSEA) Dovercampus will soon include Sin-gapore’s most energy-effi-cient office with space-savingtechniques.

The project will be spear-headed by Future Cities Labo-ratory (FCL), a research pro-gramme focused on urbansustainability. FCL is part ofSingapore ETH Centre (SEC),the only research centre out-side of Switzerland under theumbrella of the prestigiousSwiss Federal Institute ofTechnology Zürich (ETHZürich).

The 600 sqm office situat-ed in a 20,000 sqm buildingwill be the first commercialapplication of the ‘3for2’ ar-chitecture here when it iscompleted in 2015.

The ‘3for2’ concept allowsbuilding developers to con-struct three floors within thestandard space needed forconventional methods to con-struct two floors without anyimpact on perce ivedfloor-to-ceiling heights.

Currently, up to a quarterof vertical spaces in local of-fices are occupied by duct-work, structures and othertechnical systems. However,the team behind ‘3for2’ hasfound a way to greatly reducethe amount of ductwork need-ed and integrate the remain-ing ductwork into the floor,thereby saving on a largeamount of headspace.

The ‘3for2’ design alsosaves on space and energy

consumption through newconstruction technologiessuch as LED lighting panelsand passively cooled ceilingtiles.

The new office will alsoemploy a more energy effi-cient chilling system for itsair-conditioning, which ac-counts for the bulk of energycosts in modern Singapore of-

fices. This is achieved via in-creasing the overall chilledwater temperature requiredto chill a space from about 6degrees to about 17 degrees.The office is expected to con-sume 40 per cent less energythan an average office in Sin-gapore.

Reducing energy con-sumption while increasing vi-

able space seems to have hitarchitectural jackpot. Yet, asa new concept to local proper-ty developers, ‘3for2’ has yetto gain traction. In fact, theUWCSEA ‘3for2’ office is amere 3 per cent of the newbuilding’s floor space. Howev-er, the FCL team believesthat starting small is goodenough.

Dr Adam Rysanek, SEC

FCL manager of the ‘3for2’implementation at UWCSEAsaid: “Before we can reallyconsider applying our con-cept throughout a 50-storeyskyscraper, we need to makesure we get the basics right.With our project at UWCSEA,we have to first prove thatour system will deliver themost energy-efficient officespace in the region.”

TO the naked eye, the capsulesproduced by biotechnologyfirm Austrianova look likebrightly coloured balls, eachbarely a millimeter in diame-

ter.

But each one of these capsules is infact a pod capable of containing10,000 living cells.

Professor Walter Gunzburg, thechairman and chief technology officerof Austrianova, explained that the cap-sules are made of a special type of cot-ton, designed to protect the cells andcocoon them so they can grow and dothe job they need to do – for thesecells, contained in their pods, are tobe injected into the human body for avariety of potential applications –from cancer treatment to probiotics,stem cells and cosmetics.

The special cotton of which the cap-sules are made also ensure that thebody’s immune system does not re-ject the cells, he said.

“We take living cells and we mixthem with this cotton material – thisspecial proprietary cotton derivativewhich we manufacture ourselves.When you mix the two together youform these capsules, with the cells in-side.”

This is what Austrianova’sCell-in-a-Box or cell encapsulationtechnology is about – and it couldchange the way medication is admin-istered to patients.

The capsules are all porous, to al-low for the movement of substancesin and out. This way, the cells insidecan draw nutrition from outside andexpel waste; the porous membrane al-so enables useful substances pro-duced by the cell to enter the body.

Prof Gunzburg said: “What we’redoing here is making a mini implant.Instead of manufacturing a pharma-ceutical product in a factory, putting itin a bottle, sending it to the hospitaland then administering it to the pa-tient, we are actually moving the facto-ry into the patient.”

Diabetes patients, for example, areinjected with these capsules contain-ing insulin-producing cells, which canbe programmed with mechanisms toreact to the body, only producing asmuch insulin as is needed each time.

Dosing in this way will be moreprecise, compared to the convention-al method of making rough estima-tions for each dose, or relying on afixed dose regardless of changes inthe body.

The system is thus self-regulating,which takes some burden off patientsfrom having to monitor their doses.

Austrianova’s most advanced pro-gramme so far is in the treatment ofpancreatic cancer, which has been in

two clinical trials in Europe involving27 patients with advanced stages ofthe disease.

Prof Gunzburg said existing drugshave a small effect on one’s survivaland reduce pain, but cause a range ofside effects.

The pancreatic cancer patientshave been injected with capsules con-taining cells that have been genetical-ly modified to activate the chemother-apeutic chemicals these patients areadministered.

So the chemotherapy is activatedonly where these cells land up. Austri-anova’s chief executive Dr Brian Sal-mons said: “It’s like a magnifyingglass, focusing the effect on the tu-mour. This allows you to go in with alow dose, so that you don’t really getmany side effects. So you get better an-ti-tumour activity and fewer side ef-fects as well.”

Results of the trials have so farbeen promising: the patients have amedian survival period of 40 weeks,double that of the current gold stand-ard treatment. In eight of the 27 pa-tients, the tumours shrank as well.

Cell-encapsulation pioneerAustrianova is the only company inthe world using its proprietary cottonmaterial to advance cell-encapsula-tion technology.

The material of which the capsulesare made enables the capsules to befrozen and shipped around the worldand stored for up to five years. Mostother cell products need to be used im-mediately, making logistics more cost-ly and complicated.

Austrianova’s operations are pri-marily partner-based. The companyhas around 10 partners worldwide,with whom it conducts research anddevelopment and leverages on theirexpertise in order to deliver a custom-ised product.

“It’s very customised. Once the pro-duction process is set, it’s very sim-ple: you just put the cells and the cot-ton together at the beginning and thebeads come out at the end. But howyou tweak the cells, how you tweakthe cotton to make the perfect beadfor the perfect application, like thesize of the bead, the size of the holes –that’s all stuff that we tweak,” saidProf Gunzburg.

Interestingly, this business modeldiffers from what the founders of Aus-trianova initially had in mind.

The company rose in Austria, withits original focus being to develop allstages of its product for pancreaticcancer, but this was an extremely cost-ly mission.

Austrianova thus went from devel-

oping its own product to being a tech-nology platform, and this is how thecompany came to be in Singapore,known for its vibrant stem cell com-munity. Singapore became the compa-ny’s stepping stone into Asia when itset up here in 2007.

But what Singapore lacks, com-pared to Europe, was a venture capi-tal culture.

Austrianova adapted. It has sincebuilt itself here by relying on financ-ing from high-net-worth individuals.It has also placed a premium on avoid-ing risks and diversifying the compa-ny’s offerings, instead of being fo-cused on a single product as is thenorm in Europe.

Dr Salmons said: “In the past, weused to focus on our oncology prod-uct, but now, we’ve got many horsesin the race, different ways to makeproducts and generate income.

“As a company offering a technolo-

gy platform, we work with other part-ners who have specific needs. So theyhave cells which they would like touse for some particular application;they come to us and we co-developthe product with them.”

Prof Gunzburg agreed, saying:“The most important thing is to keepthe company liquid and move the com-pany forward, and you have to find away to do that, whatever it takes.”

Subsidiary in ThailandThe company’s cash flow comes fromits clients, who pay for every stage oftheir product development with Aus-trianova.

It also places an emphasis on mini-mising costs and keeping the compa-ny’s burn rate low by outsourcingfunctions on a pay-by-use system; itdoes this with its financial services,business development and legal ad-vice functions.

Austrianova has also set up a sub-sidiary in Thailand, which it fullyowns. This unit concentrates on themanufacturing of medical productsfor global export and be off theground by the end of the year.

Thailand was chosen because it ischeaper, more cost-efficient than Sin-gapore, said Prof Gunzburg. The com-pany hopes to begin manufacturingits pancreatic cancer product for fur-ther patient trials by the first half ofnext year.

Dr Salmons said: “Running a com-pany is not just about making money.It is important to bring your investorsa return, but it is also because there’sa medical need out there for which wewant to develop products that will ac-tually help patients eventually.”

Prof Gunzburg said: “We’re build-ing a company that should grow andbe around in 10 years’ time. We aretrying to build something that is sus-tainable.”

By LEE [email protected]@LeeMeixianBT

MORE companies across the world areengaging in environmental and sociallyresponsible activities - not simply forbrand building or altruistic reasons, butsimply because it makes good financialsense.

This was according to the latest re-search by Grant Thornton which hasbeen tracking business attitudes to cor-porate social responsibility (CSR) since2008.

In Singapore, the top five drivers to-wards more sustainable business prac-

tices are: cost management (73 percent), followed by client or consumer de-mand (62 per cent), “because it is theright thing to do” (55 per cent), tax relief(51 per cent), and recruitment and re-tention of staff (44 per cent).

For instance, over the last 12months, more than half of Singaporebusinesses have started calculatingtheir carbon footprint. This is the No 1CSR initiative adopted here.

Singapore companies also donateproducts or services to community andcharities (47 per cent), partner a charita-ble organisation for philanthropy (45per cent) and donate money (43 percent).

The survey of 2,500 businesses in 34economies was conducted in May thisyear, and interviewed C-Suite and othersenior decision-makers in mid-marketbusinesses - of which 50 were Singa-pore business leaders.

It also found that more companiesare also reporting on sustainability,while a majority now view integrated re-porting as best practice.

Since Singapore Exchange intro-duced sustainability reporting guide-lines in 2011, many major corporationsin Singapore have included a CSR com-ponent in their business framework toalign with the global investor expecta-tions, it said.

Austrianova runs a tight ship here as it grows its business of delivering medical treatments in ‘capsules’. AMANDA EBER reports

By CAI [email protected]

FRAUDSTERS are operating throughmoney mules and even using unwit-ting blogshop owners to scam onlineshoppers, said the Singapore PoliceForce yesterday.

New statistics indicate that cheat-ing cases involving e-commercejumped 425 per cent in the first halfof this year from the correspondingperiod a year ago.

Lian Ghim Hua, the deputy assist-ant commissioner of police and com-mander of the Ang Mo Kio Police Divi-sion, said: “I think it’s a general reflec-tion of how more and more peoplehave started to engage in e-com-merce... And with that, criminals arealso looking to exploit this space topursue some of their illicit activities.”

Multiple payment online purchase(MPOP) scams, for example, have ris-en from 13 in the first half of last yearto 302 reported cases in the first halfof this year.

The amounts swindled are now al-so larger – at least $237,000 in thefirst half of this year from S$28,000last year.

In MPOP scams, the perpetratorsput up online advertisements offeringto sell items at heavy discounts. Theirvictims, drawn to the deals, contactthem and are instructed to send pay-ment, typically through bank trans-

fers. The cash goes to local accountsheld by money mules, who then trans-fer the sum to the masterminds.

The goods are never delivered.When the victims enquire on the de-lay, they are told to pay additionalfees in order to receive their orders;the victims pay until they realise theyhave been duped.

Police have stepped up effortsagainst these fraudsters. In a two-dayoperation that ended yesterday, theyarrested six men and 12 women, Sin-gaporeans aged 16 to 47 suspected ofhaving been money mules for MPOPscams.

Preliminary investigations suggestthat the masterminds are in Africa.Some money mules are recruited un-der the pretext of a work-from-homejob, others, with promises of love.

In rare cases, scammers have alsooperated through blogshop owners.

These scammers contact blogshopowners, feigning interest their prod-ucts. They then go to their victims, in-structing them to deposit amounts farhigher than the price of those items in-to the bank account of the blogshop.

The scammers then close in, tell-ing the blogshop owners that theyhad mistakenly overpaid, and askthat these owners transfer the excesspayment to their bank account.

Police have warned members ofthe public to be wary of deals that aretoo good to be true, and to buy onlyfrom sellers with strong trackrecords.

Legitimate businesses will find itharder to get a footing in cyberspace;new online shops, with no history tospeak of, will find it even more diffi-cult to build their customer base.

More firms find CSR makes financial sense

Biotech firm a leader in cell-encapsulation

Rising cyber scamsmake it toughfor genuine businessesto get firm foothold

UWC Dover campusoffice to also haveenergy-efficientsolutions

Cell-in-a-Box know-how: The key personnel in Austrianova are (from left) chief operating officer Dr John Dangerfield, chairman and chief technologyofficer Dr Walter Gunzburg and president and chief executive officer Dr Brian Salmons PHOTO: YEN MENG JIIN

Conventional building ‘3for2’ building

Flat, cold water radiators attached to ceiling

Bulky mechanical equipment hidden along exterior of facade

Sloped windows for improved daylight quality

Ductwork integrated into concrete slabs

Sour

ce: F

utur

e Ci

ties L

abor

ator

y 201

4

Test case for space saving building method

This profile is the 13th of a series o ffeatures on the 16 finalists of theEmerging Enterprise Award 2014.

Jointly presented by The Business Timesand OCBC Bank, the Emerging Enterprise

Award 2014 recognises promising enterprises and startups which are up to

10 years old and have an annual turnoverof S$15 million or less. It is supported by

RSM Chio Lim, MasterCard, SingTel,ACORN Marketing & Research

Consultants, INSEAD and SPRING Singapore. The winners will be unveiled

at a gala dinner on August 29.

Online scamsup 425% in H1from year ago

The Business Times, Thursday, August 21, 2014 SINGAPORE NEWS 9